RNA methylation, homologous recombination repair and therapeutic resistance.

[1]  Junhong Han,et al.  RNA modification: mechanisms and therapeutic targets , 2023, Molecular Biomedicine.

[2]  Christine Thompson,et al.  Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer , 2023, BMC Cancer.

[3]  Junjie Chen,et al.  FACS-based genome-wide CRISPR screens define key regulators of DNA damage signaling pathways. , 2023, Molecular cell.

[4]  J. Vertemara,et al.  Dynamic Properties of the DNA Damage Response Mre11/Rad50 Complex , 2023, International journal of molecular sciences.

[5]  R. Liu,et al.  PRMT1 methylation of WTAP promotes multiple myeloma tumorigenesis by activating oxidative phosphorylation via m6A modification of NDUFS6 , 2023, Cell death & disease.

[6]  Xin Xu,et al.  FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1 , 2023, EMBO reports.

[7]  W. Sun,et al.  HDAC-an important target for improving tumor radiotherapy resistance , 2023, Frontiers in oncology.

[8]  Meng-Xin Tian,et al.  Methyltransferase like 3 inhibition limits intrahepatic cholangiocarcinoma metabolic reprogramming and potentiates the efficacy of chemotherapy , 2023, Oncogene.

[9]  Jinfang Zhang,et al.  Deubiquitinase USP9X stabilizes RNA m6A demethylase ALKBH5 and promotes acute myeloid leukemia cell survival , 2023, The Journal of biological chemistry.

[10]  Wei Wang,et al.  E2F3 induces DNA damage repair, stem-like properties and therapy resistance in breast cancer. , 2023, Biochimica et Biophysica Acta - Molecular Basis of Disease.

[11]  Zhe S Chen,et al.  Epigenetic modification of m6A regulator proteins in cancer , 2023, Molecular Cancer.

[12]  Chuan Wang,et al.  m6A methylation regulates hypoxia-induced pancreatic cancer glycolytic metabolism through ALKBH5-HDAC4-HIF1α positive feedback loop , 2023, Oncogene.

[13]  Zekuan Xu,et al.  Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification , 2023, Oncogene.

[14]  Shilong Zheng,et al.  Discovery of berberine analogs as potent and highly selective p300/CBP HAT inhibitors. , 2023, Bioorganic chemistry.

[15]  M. Zhou,et al.  RNA modifications in cancer , 2023, British Journal of Cancer.

[16]  W. Liu,et al.  Deubiquitinase USP13 regulates glycolytic reprogramming and progression in osteosarcoma by stabilizing METTL3/m6A/ATG5 axis , 2023, International journal of biological sciences.

[17]  Zhenshuang Wang,et al.  De-ubiquitination of SAMHD1 by USP7 promotes DNA damage repair to overcome oncogenic stress and affect chemotherapy sensitivity , 2023, Oncogene.

[18]  Weitao Shen,et al.  METTL3 promotes chemoresistance in small cell lung cancer by inducing mitophagy , 2023, Journal of Experimental & Clinical Cancer Research.

[19]  J. Lysaght,et al.  The impact of histone deacetylase inhibitors on immune cells and implications for cancer therapy. , 2023, Cancer letters.

[20]  Md. Arafat Hossain Khan,et al.  FOXM1: A small fox that makes more tracks for cancer progression and metastasis. , 2023, Seminars in cancer biology.

[21]  Xiao-long Tan,et al.  Knockdown of UBE2I inhibits tumorigenesis and enhances chemosensitivity of cholangiocarcinoma via modulating p27kip1 nuclear export , 2023, Molecular carcinogenesis.

[22]  B. Graves,et al.  FT-6876, a Potent and Selective Inhibitor of CBP/p300, is Active in Preclinical Models of Androgen Receptor-Positive Breast Cancer , 2023, Targeted Oncology.

[23]  Shunping Yan,et al.  The SMC5/6 complex recruits the PAF1 complex to facilitate DNA double‐strand break repair in Arabidopsis , 2023, The EMBO journal.

[24]  T. McKinsey,et al.  Histone Deacetylases: Molecular Mechanisms and Therapeutic Implications for Muscular Dystrophies , 2023, International journal of molecular sciences.

[25]  Erdem Sendinc,et al.  RNA m6A methylation across the transcriptome. , 2023, Molecular cell.

[26]  Reham M. Elhassan,et al.  Targeting histone deacetylases for cancer therapy: Trends and challenges , 2023, Acta pharmaceutica Sinica. B.

[27]  Wentao Wang,et al.  METTL3 protects METTL14 from STUB1‐mediated degradation to maintain m6A homeostasis , 2023, EMBO reports.

[28]  R. Murakami,et al.  FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells. , 2023, Laboratory investigation; a journal of technical methods and pathology.

[29]  Boqi Hu,et al.  Oncogenic lncRNA MALAT-1 recruits E2F1 to upregulate RAD51 expression and thus promotes cell autophagy and tumor growth in non-small cell lung cancer. , 2023, Pulmonary pharmacology & therapeutics.

[30]  H. Ogiwara,et al.  Discovery of DS-9300: A Highly Potent, Selective, and Once-Daily Oral EP300/CBP Histone Acetyltransferase Inhibitor. , 2022, Journal of Medicinal Chemistry.

[31]  S. Fan,et al.  RNF126‐Mediated MRE11 Ubiquitination Activates the DNA Damage Response and Confers Resistance of Triple‐Negative Breast Cancer to Radiotherapy , 2022, Advanced science.

[32]  Zheng Li,et al.  N^6-methyladenosine-modified USP13 induces pro-survival autophagy and imatinib resistance via regulating the stabilization of autophagy-related protein 5 in gastrointestinal stromal tumors , 2022, Cell Death & Differentiation.

[33]  R. Deng,et al.  Bone Marrow Mesenchymal Stem Cell-Derived Exosomes Inhibit Triple-Negative Breast Cancer Cell Stemness and Metastasis via an ALKBH5-Dependent Mechanism , 2022, Cancers.

[34]  Hui Du,et al.  YTHDF3 mediates HNF1α regulation of cervical cancer radio‐resistance by promoting RAD51D translation in an m6A‐dependent manner , 2022, The FEBS journal.

[35]  C. Ji,et al.  HDAC1/3-dependent moderate liquid–liquid phase separation of YY1 promotes METTL3 expression and AML cell proliferation , 2022, Cell Death & Disease.

[36]  O. Takeuchi,et al.  The N6-methyladenosine methyltransferase METTL16 enables erythropoiesis through safeguarding genome integrity , 2022, Nature Communications.

[37]  Douglas W. Thomson,et al.  Discovery of Proline-Based p300/CBP Inhibitors Using DNA-Encoded Library Technology in Combination with High-Throughput Screening. , 2022, Journal of medicinal chemistry.

[38]  P. Pan,et al.  A small molecule inhibitor of the UBE2F-CRL5 axis induces apoptosis and radiosensitization in lung cancer , 2022, Signal Transduction and Targeted Therapy.

[39]  Yongheng Chen,et al.  m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA , 2022, Cancers.

[40]  Qiu-ming He,et al.  The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer , 2022, PLoS genetics.

[41]  Lin Xiao,et al.  METTL3 regulates m6A methylation of PTCH1 and GLI2 in Sonic hedgehog signaling to promote tumor progression in SHH-medulloblastoma. , 2022, Cell reports.

[42]  D. Pei,et al.  METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA , 2022, Oncogene.

[43]  T. Rana,et al.  Rational Design and Optimization of m6A-RNA Demethylase FTO Inhibitors as Anticancer Agents , 2022, Journal of medicinal chemistry.

[44]  Hao Shen,et al.  N6-methyladenosine (m6A) methyltransferase METTL3 regulates sepsis-induced myocardial injury through IGF2BP1/HDAC4 dependent manner , 2022, Cell Death Discovery.

[45]  Jiawang Zhou,et al.  RNA m1A methylation regulates glycolysis of cancer cells through modulating ATP5D , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Q. Pan,et al.  WTAP-mediated N6-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy , 2022, Cellular & Molecular Biology Letters.

[47]  Xiao Wang,et al.  TRIM56 Reduces Radiosensitization of Human Glioblastoma by Regulating FOXM1-Mediated DNA Repair , 2022, Molecular Neurobiology.

[48]  Qing‐Yu He,et al.  Anti-HIV drug elvitegravir suppresses cancer metastasis via increased proteasomal degradation of m6A methyltransferase METTL3. , 2022, Cancer research.

[49]  Lingfeng He,et al.  METTL3 promotes homologous recombination repair and modulates chemotherapeutic response in breast cancer by regulating the EGF/RAD51 axis , 2022, eLife.

[50]  Henry Yang,et al.  Loss of METTL3 attenuates blastic plasmacytoid dendritic cell neoplasm response to PRMT5 inhibition via IFN signaling , 2022, Blood Advances.

[51]  R. Jiang,et al.  METTL3 stabilizes HDAC5 mRNA in an m6A-dependent manner to facilitate malignant proliferation of osteosarcoma cells , 2022, Cell death discovery.

[52]  K. Tsujikawa,et al.  Discovery of two novel ALKBH5 selective inhibitors that exhibit uncompetitive or competitive type and suppress the growth activity of glioblastoma multiforme , 2022, Chemical biology & drug design.

[53]  Li Yang,et al.  IKZF1 selectively enhances homologous recombination repair by interacting with CtIP and USP7 in multiple myeloma , 2022, International journal of biological sciences.

[54]  Siyuan Zheng,et al.  M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression. , 2022, Cancer research.

[55]  L. Zou,et al.  FMRP promotes transcription-coupled homologous recombination via facilitating TET1-mediated m5C RNA modification demethylation , 2022, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Emma L. Wilkinson,et al.  Roles of RNA Modifications in Diverse Cellular Functions , 2022, Frontiers in Cell and Developmental Biology.

[57]  L. Altucci,et al.  HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation , 2022, Journal of experimental & clinical cancer research : CR.

[58]  Liying Hao,et al.  YTHDF1 promotes breast cancer cell growth, DNA damage repair and chemoresistance , 2022, Cell Death & Disease.

[59]  R. Ling,et al.  PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[60]  Z. Szallasi,et al.  RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer , 2022, Science Advances.

[61]  J. Oliveira,et al.  METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability , 2022, Cellular and Molecular Life Sciences.

[62]  Shuangbing Xu,et al.  Arginine methyltransferase PRMT5 methylates and destabilizes Mxi1 to confer radioresistance in non-small cell lung cancer. , 2022, Cancer letters.

[63]  F. Bertucci,et al.  BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells , 2022, Cell Death & Disease.

[64]  Wei Zhao,et al.  METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner , 2022, Oncogene.

[65]  Sharon Y. R. Dent,et al.  Now open: Evolving insights to the roles of lysine acetylation in chromatin organization and function. , 2022, Molecular cell.

[66]  Hongsheng Wang,et al.  RNA m6A methylation regulates the dissemination of cancer cells via modulating expression and membrane localization of β-catenin. , 2022, Molecular therapy : the journal of the American Society of Gene Therapy.

[67]  J. L. Ding,et al.  E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers. , 2022, Biochimica et biophysica acta. Reviews on cancer.

[68]  Yun-Gen Xu,et al.  FDI-6 inhibits the expression and function of FOXM1 to sensitize BRCA-proficient triple-negative breast cancer cells to Olaparib by regulating cell cycle progression and DNA damage repair , 2021, Cell Death & Disease.

[69]  G. Stewart,et al.  Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair , 2021, Nature Communications.

[70]  U. Kikkawa,et al.  Histone deacetylase 6 acts upstream of DNA damage response activation to support the survival of glioblastoma cells , 2021, Cell Death & Disease.

[71]  D. Lin,et al.  NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization , 2021, Oncogene.

[72]  Jiawang Zhou,et al.  A novel inhibitor of N6-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities , 2021, Acta pharmaceutica Sinica. B.

[73]  Xiao-shu Cheng,et al.  De-ubiquitination of p300 by USP12 Critically Enhances METTL3 Expression and Ang II-induced Cardiac Hypertrophy. , 2021, Experimental cell research.

[74]  A. Maitra,et al.  PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma , 2021, Nature Communications.

[75]  A. Groth,et al.  BARD1 reads H2A lysine 15 ubiquitination to direct homologous recombination , 2021, Nature.

[76]  N. Johnson,et al.  RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage , 2021, Nature Communications.

[77]  Liyun Shen,et al.  ALKBH5‐mediated m6A‐demethylation of USP1 regulated T‐cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B , 2021, Molecular carcinogenesis.

[78]  Dahua Chen,et al.  Arginine methylation of METTL14 promotes RNA N6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells , 2021, Nature Communications.

[79]  M. Karelson,et al.  Rational Design of Novel Anticancer Small-Molecule RNA m6A Demethylase ALKBH5 Inhibitors , 2021, ACS omega.

[80]  L. Du,et al.  USP48 Is Upregulated by Mettl14 to Attenuate Hepatocellular Carcinoma via Regulating SIRT6 Stabilization , 2021, Cancer Research.

[81]  Andrew J. Bannister,et al.  Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia , 2021, Nature.

[82]  Andrew J. Wilson,et al.  Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer. , 2021, Gynecologic oncology.

[83]  Chunyang Li,et al.  SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation , 2021, Cell reports.

[84]  Grant W. Brown,et al.  RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors. , 2021, The Journal of clinical investigation.

[85]  Jeremy M. Stark,et al.  m6A deposition is regulated by PRMT1‐mediated arginine methylation of METTL14 in its disordered C‐terminal region , 2021, The EMBO journal.

[86]  E. Cohen-Jonathan-Moyal,et al.  The m6A RNA Demethylase ALKBH5 Promotes Radioresistance and Invasion Capability of Glioma Stem Cells , 2020, Cancers.

[87]  Zhuo Wang,et al.  FZD5 contributes to TNBC proliferation, DNA damage repair and stemness , 2020, Cell Death & Disease.

[88]  Chuan He,et al.  Stabilization of ERK-Phosphorylated METTL3 by USP5 Increases m6A Methylation. , 2020, Molecular cell.

[89]  Danzhi Huang,et al.  METTL3 Inhibitors for Epitranscriptomic Modulation of Cellular Processes , 2020, bioRxiv.

[90]  F. Peng,et al.  Oncogenic AURKA-enhanced N6-methyladenosine modification increases DROSHA mRNA stability to transactivate STC1 in breast cancer stem-like cells , 2020, Cell Research.

[91]  Wengong Wang,et al.  METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. , 2020, Molecular cell.

[92]  L. Zou,et al.  m5C modification of mRNA serves a DNA damage code to promote homologous recombination , 2020, Nature Communications.

[93]  I. Chu,et al.  Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance , 2020, Cancers.

[94]  Yusuf Mert Demirlenk,et al.  Targeted CRISPR screening identifies PRMT5 as synthetic lethality combinatorial target with gemcitabine in pancreatic cancer cells , 2020, Proceedings of the National Academy of Sciences.

[95]  T. J. McCorvie,et al.  Structural basis of homologous recombination , 2019, Cellular and Molecular Life Sciences.

[96]  K. Helin,et al.  PRMT5 inhibition modulates E2F1 methylation and gene regulatory networks leading to therapeutic efficacy in JAK2V617F mutant MPN. , 2019, Cancer discovery.

[97]  B. Liu,et al.  E2F1 acetylation directs p300/CBP-mediated histone acetylation at DNA double-strand breaks to facilitate repair , 2019, Nature Communications.

[98]  Q. Ding,et al.  METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance , 2019, Gut.

[99]  Jun Xia,et al.  RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay. , 2019, Molecular cell.

[100]  S. Smerdon,et al.  KAT2-mediated acetylation switches the mode of PALB2 chromatin association to safeguard genome integrity , 2019, eLife.

[101]  Z. Lou,et al.  A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair , 2019, Cell Death & Disease.

[102]  Yi Han,et al.  The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. , 2019, Biochemical and biophysical research communications.

[103]  F. He,et al.  The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors , 2019, Nature Communications.

[104]  S. Pyndiah,et al.  Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin , 2019, The Journal of Biological Chemistry.

[105]  B. Leiby,et al.  PARP‐1 regulates DNA repair factor availability , 2018, EMBO molecular medicine.

[106]  B. Garcia,et al.  Phosphorylation of TIP60 Suppresses 53BP1 Localization at DNA Damage Sites , 2018, Molecular and Cellular Biology.

[107]  Fuquan Yang,et al.  Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis , 2018, The Journal of clinical investigation.

[108]  R. Verdun,et al.  PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes. , 2018, Cell reports.

[109]  I. Jurisica,et al.  Ubiquitin ligase RNF8 suppresses Notch signaling to regulate mammary development and tumorigenesis , 2018, The Journal of clinical investigation.

[110]  K. Ligon,et al.  Dual HDAC and PI3K Inhibition Abrogates NFκB- and FOXM1-Mediated DNA Damage Response to Radiosensitize Pediatric High-Grade Gliomas. , 2018, Cancer research.

[111]  S. Xi,et al.  Deregulation of UBE2C-mediated autophagy repression aggravates NSCLC progression , 2018, Oncogenesis.

[112]  W. Heyer,et al.  Homologous recombination and the repair of DNA double-strand breaks , 2018, The Journal of Biological Chemistry.

[113]  Jill A. Madden,et al.  Olaparib-induced Adaptive Response Is Disrupted by FOXM1 Targeting that Enhances Sensitivity to PARP Inhibition , 2018, Molecular Cancer Research.

[114]  K. Somasundaram,et al.  Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance , 2018, Oncogene.

[115]  T. Stankovic,et al.  USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status. , 2017, Blood.

[116]  Bin Wang,et al.  RNF8- and Ube2S-Dependent Ubiquitin Lysine 11-Linkage Modification in Response to DNA Damage. , 2017, Molecular cell.

[117]  Samir Adhikari,et al.  5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.

[118]  Chuan He,et al.  m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program. , 2017, Cancer cell.

[119]  G. Stewart,et al.  PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination , 2017, Molecular cell.

[120]  B. Price,et al.  Epigenetic therapy with inhibitors of histone methylation suppresses DNA damage signaling and increases glioma cell radiosensitivity , 2017, Oncotarget.

[121]  Chuan He,et al.  m6A RNA methylation regulates the UV-induced DNA damage response , 2017, Nature.

[122]  Michael D. Brooks,et al.  RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer , 2016, Clinical Cancer Research.

[123]  Z. Lou,et al.  A phosphorylation–deubiquitination cascade regulates the BRCA2–RAD51 axis in homologous recombination , 2016, Genes & development.

[124]  Y. Kee,et al.  The USP1-UAF1 complex interacts with RAD51AP1 to promote homologous recombination repair , 2016, Cell cycle.

[125]  W. Gilbert,et al.  Messenger RNA modifications: Form, distribution, and function , 2016, Science.

[126]  B. Kaina,et al.  Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance. , 2016, Cancer research.

[127]  Chuanzhao Zhang,et al.  Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA , 2016, Proceedings of the National Academy of Sciences.

[128]  T. Sixma,et al.  BAP1/ASXL1 recruitment and activation for H2A deubiquitination , 2016, Nature Communications.

[129]  Carlo M. Croce,et al.  miR-302b enhances breast cancer cell sensitivity to cisplatin by regulating E2F1 and the cellular DNA damage response , 2015, Oncotarget.

[130]  K. Furuya,et al.  Acetylation of Histone H2AX at Lys 5 by the TIP60 Histone Acetyltransferase Complex Is Essential for the Dynamic Binding of NBS1 to Damaged Chromatin , 2015, Molecular and Cellular Biology.

[131]  Gang Li,et al.  Regulation of E2 Promoter Binding Factor 1 (E2F1) Transcriptional Activity through a Deubiquitinating Enzyme, UCH37* , 2015, The Journal of Biological Chemistry.

[132]  Matylda Sczaniecka-Clift,et al.  Systematic E2 screening reveals a UBE2D–RNF138–CtIP axis promoting DNA repair , 2015, Nature Cell Biology.

[133]  Zhihui Feng,et al.  RNF126 promotes homologous recombination via regulation of E2F1-mediated BRCA1 expression , 2015, Oncogene.

[134]  G. Wani,et al.  USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168* , 2015, Cell cycle.

[135]  B. Price,et al.  DNA double-strand breaks promote methylation of histone H3 on lysine 9 and transient formation of repressive chromatin , 2014, Proceedings of the National Academy of Sciences.

[136]  Anton Simeonov,et al.  A selective USP1-UAF1 inhibitor links deubiquitination to DNA damage responses. , 2014, Nature chemical biology.

[137]  Helen Yu,et al.  Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair , 2013, Proceedings of the National Academy of Sciences.

[138]  T. Rajkumar,et al.  Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole , 2013, Cellular Oncology.

[139]  Holly McDonough,et al.  The Ubiquitin Ligase CHIP Prevents SirT6 Degradation through Noncanonical Ubiquitination , 2013, Molecular and Cellular Biology.

[140]  P. Munster,et al.  Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling , 2013, Molecular Cancer Therapeutics.

[141]  Lei Li,et al.  Histone Acetyltransferase 1 Promotes Homologous Recombination in DNA Repair by Facilitating Histone Turnover* , 2013, The Journal of Biological Chemistry.

[142]  Sean D. Taverna,et al.  Selective Inhibition of p300 HAT Blocks Cell Cycle Progression, Induces Cellular Senescence and Inhibits the DNA Damage Response in Melanoma Cells , 2013, The Journal of investigative dermatology.

[143]  R. Greenberg,et al.  Acetylation Limits 53BP1 Association with Damaged Chromatin to Promote Homologous Recombination , 2012, Nature Structural &Molecular Biology.

[144]  Takashi Kohno,et al.  CBP and p300 Histone Acetyltransferases Contribute to Homologous Recombination by Transcriptionally Activating the BRCA1 and RAD51 Genes , 2012, PloS one.

[145]  K. Matsuo,et al.  RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the absence of BRCA1 and 53BP1. , 2012, Cancer research.

[146]  Lara J. Monteiro,et al.  The p38 MAPK–MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment , 2012, Molecular Cancer Research.

[147]  R. Hay,et al.  SUMO-targeted ubiquitin E3 ligase RNF4 is required for the response of human cells to DNA damage. , 2012, Genes & development.

[148]  S. Jackson,et al.  RNF4, a SUMO-targeted ubiquitin E3 ligase, promotes DNA double-strand break repair. , 2012, Genes & development.

[149]  S. Richard,et al.  The MRE11 GAR motif regulates DNA double-strand break processing and ATR activation , 2011, Cell Research.

[150]  A. Seluanov,et al.  SIRT6 Promotes DNA Repair Under Stress by Activating PARP1 , 2011, Science.

[151]  Lara J. Monteiro,et al.  ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance , 2011, Molecular Cancer Therapeutics.

[152]  Jie Chen,et al.  E2F1 promotes the recruitment of DNA repair factors to sites of DNA double-strand breaks , 2011, Cell cycle.

[153]  A. D’Andrea,et al.  The USP1/UAF1 Complex Promotes Double-Strand Break Repair through Homologous Recombination , 2011, Molecular and Cellular Biology.

[154]  Bernhard Kuster,et al.  Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. , 2011, Molecular cell.

[155]  H. Tauchi,et al.  Regulation of homologous recombination by RNF20-dependent H2B ubiquitination. , 2011, Molecular cell.

[156]  H. Hang,et al.  A role for the arginine methylation of Rad9 in checkpoint control and cellular sensitivity to DNA damage , 2011, Nucleic acids research.

[157]  S. Jackson,et al.  Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining , 2010, Nature Structural &Molecular Biology.

[158]  Ken Yamamoto,et al.  P300/CBP‐associated factor regulates Y‐box binding protein‐1 expression and promotes cancer cell growth, cancer invasion and drug resistance , 2010, Cancer science.

[159]  M. Hedayati,et al.  Downregulation of Homologous Recombination DNA Repair Genes by HDAC Inhibition in Prostate Cancer Is Mediated through the E2F1 Transcription Factor , 2010, PloS one.

[160]  Lara J. Monteiro,et al.  FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells , 2010, Molecular Cancer Research.

[161]  J. Tyler,et al.  CBP/p300-mediated acetylation of histone H3 on lysine 56 , 2009, Nature.

[162]  En Li,et al.  A Mouse PRMT1 Null Allele Defines an Essential Role for Arginine Methylation in Genome Maintenance and Cell Proliferation , 2009, Molecular and Cellular Biology.

[163]  J. Ellenberg,et al.  RNF168 Binds and Amplifies Ubiquitin Conjugates on Damaged Chromosomes to Allow Accumulation of Repair Proteins , 2009, Cell.

[164]  S. Richard,et al.  A Glycine-Arginine Domain in Control of the Human MRE11 DNA Repair Protein , 2008, Molecular and Cellular Biology.

[165]  Laurence Pelletier,et al.  Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase , 2007, Science.

[166]  Michael B. Yaffe,et al.  RNF8 Transduces the DNA-Damage Signal via Histone Ubiquitylation and Checkpoint Protein Assembly , 2007, Cell.

[167]  Jiri Bartek,et al.  RNF8 Ubiquitylates Histones at DNA Double-Strand Breaks and Promotes Assembly of Repair Proteins , 2007, Cell.

[168]  Yingli Sun,et al.  DNA Damage-Induced Acetylation of Lysine 3016 of ATM Activates ATM Kinase Activity , 2007, Molecular and Cellular Biology.

[169]  H. Kimura,et al.  DNA Damage-Dependent Acetylation and Ubiquitination of H2AX Enhances Chromatin Dynamics , 2007, Molecular and Cellular Biology.

[170]  D. Ruderman,et al.  The ubiquitin-conjugating enzyme E2-EPF is overexpressed in primary breast cancer and modulates sensitivity to topoisomerase II inhibition. , 2007, Neoplasia.

[171]  R. Costa,et al.  Chk2 Mediates Stabilization of the FoxM1 Transcription Factor To Stimulate Expression of DNA Repair Genes , 2006, Molecular and Cellular Biology.

[172]  Xiaofeng Jiang,et al.  Inhibition of histone acetyltransferase activity by anacardic acid sensitizes tumor cells to ionizing radiation , 2006, FEBS letters.

[173]  J. Tyler,et al.  Localized Histone Acetylation and Deacetylation Triggered by the Homologous Recombination Pathway of Double-Strand DNA Repair , 2005, Molecular and Cellular Biology.

[174]  François-Michel Boisvert,et al.  Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. , 2005, Genes & development.

[175]  A. Gulino,et al.  Specific Role for p300/CREB-binding Protein-associated Factor Activity in E2F1 Stabilization in Response to DNA Damage* , 2004, Journal of Biological Chemistry.

[176]  Tapas K. Kundu,et al.  Small Molecule Modulators of Histone Acetyltransferase p300* , 2003, Journal of Biological Chemistry.

[177]  J. Nevins,et al.  Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. , 2001, Genes & development.

[178]  Z. Herceg,et al.  Histone acetylation by Trrap–Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks , 2006, Nature Cell Biology.